Therefore, a multivariable Cox model that included the interaction between chemotherapy and cancer cell PD-L2 expression was used to evaluate PFS in ER+ breast cancer patients with or without chemotherapy (Data Supplement). The gene discussed is PDCD1LG2; the disease is breast carcinoma.